腹腔镜与开腹胃癌手术对肌少症患者的获益:倾向性评分匹配分析
本研究纳入2003年至2019年间604例连续胃癌手术患者,经1:1倾向性评分匹配后,在肌少症与非肌少症患者中比较腹腔镜胃切除(LG)与开腹胃切除(OG)的短期和长期结局。结果显示两组并发症无显著差异,5年总生存与疾病特异生存相似,但肌少症患者中LG的5年非胃癌相关生存优于OG(88.3% vs. 78.1%,P=0.048)。
要点
- 肌少症胃癌患者中,LG与OG并发症及5年总生存无显著差异。
- 肌少症患者LG的5年非胃癌相关生存优于OG(88.3% vs. 78.1%,P=0.048)。
- 非肌少症患者中LG未显示非胃癌相关生存获益。
核心结论
- 对于可切除胃癌,无论有无肌少症,LG在并发症和结局方面不劣于OG。
- 两种术式总生存无差异,但LG可能降低肌少症患者非胃癌相关疾病的死亡率。
研究设计与样本
- 采用1:1倾向性评分匹配后,在肌少症与非肌少症患者中比较LG与OG的短期和长期结局。
主要发现
- 在肌少症和非肌少症患者中,LG组手术时间显著长于OG组,但出血量更少。
- 两组并发症无显著差异。
- 肌少症和非肌少症患者中,LG与OG的5年总生存和疾病特异生存相似。
- 肌少症患者中,LG的5年非胃癌相关生存高于OG(88.3% vs. 78.1%,P=0.048),非肌少症患者中无此差异。
临床怎么用
- 肌少症胃癌患者选择LG可能有助于降低非胃癌相关死亡风险,但需结合手术时间和出血量等短期结局综合评估。
- LG可作为肌少症胃癌患者可切除病例的合理术式选择,不增加并发症且总生存不劣于OG。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laparoscopic gastrectomy (LG) is performed widely, but whether LG is the optimal treatment for sarcopenic gastric cancer patients is unclear. This study aimed to determine whether LG is particularly beneficial for gastric cancer patients with sarcopenia. METHODS: We collected data concerning 604 consecutive patients who underwent gastrectomy for gastric cancer between January 2003 and December 2019. After adjustment using one-to-one propensity score matching, short-term and long-term outcomes were compared between LG and open gastrectomy (OG) groups among patients with sarcopenia and those without. RESULTS: Among patients with and without sarcopenia, the LG group had a significantly longer operative time but less blood loss than the OG group. The two groups showed no significant differences regarding complications. Although 5-year overall and disease-specific survival were similar between LG and OG groups among patients with and without sarcopenia, LG was associated with greater 5-year non-gastric cancer-related survival than OG among patients with sarcopenia (88.3% vs. 78.1%, P = 0.048), but not those without. CONCLUSION: LG for resectable gastric cancer was not inferior to OG regarding complications and outcomes in patients with or without sarcopenia. No difference in overall survival was evident between these approaches, but LG may lessen mortality from conditions unrelated to gastric cancer in sarcopenic patients.
引用
- Uchida T, Sekine R, Matsuo K, et al. Benefit of laparoscopic compared to standard open gastric cancer surgery for sarcopenic patients: a propensity score-matching analysis. Surg Endosc. 2022. PMID: 35840711. doi:10.1007/s00464-022-09416-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。